Table 1 Antimicrobial resistance pattern among isolates from surgical site infections
Antibiotics | Bacteria isolates (N = 304) | |||||||
|---|---|---|---|---|---|---|---|---|
E.coli(n = 72) | Klebsiella spp(n = 39) | Acinetobacter spp(n = 52) | P.aeruginosa(n = 12) | Other g- (n = 34) | S. aureus(n = 64) | Enterococcus spp(n = 23) | Other g + (n = 08) | |
Ampicillin | 100.0% | 100.0% | NA | NA | 97.1% | 100.0% | 30.0% | 50.0% |
Piperacillin | NA | NA | 100.0% | 66.7% | NA | NA | NA | NA |
TZP * | 30.6% | 38.5% | 53.8% | 16.7% | 32.4% | NA | NA | NA |
AMC + | 90.3% | 100.0% | NA | NA | 94.1% | NA | NA | NA |
TMP-SMX Ă— | 86.1% | 92.3% | 98.0% | 100.0% | 94.1% | 89.1% | NA | 80.0% |
Tetracycline | 72.2% | 76.9% | 65.4% | 100.0% | 82.4% | 42.2% | 74.0% | 62.5% |
Ciprofloxacin | 72.2% | 66.6% | 77.0% | 16.7% | 47.1% | 29.7% | 60.9% | 50.0% |
Chloramphenicol | 41.7% | 71.8% | NA | NA | 70.6% | 15.6% | 30.4% | 37.5% |
Gentamicin | 54.2% | 76.9% | 88.5% | 16.7% | 76.5% | 18.8% | 21.7%** | 50.0% |
Amikacin | 4.2% | 2.6% | 32.7% | 8.3% | 0.0% | NA | NA | NA |
Ceftriaxone | 77.8% | 92.3% | NA | NA | 67.6% | NA | NA | NA |
Ceftazidime | 77.8% | 87.2% | 90.4% | 25.0% | 61.8% | NA | NA | NA |
Cefepime | 69.4% | 87.2% | 61.5% | 16.7% | 38.2% | NA | NA | NA |
Imipenem | 0.0% | 0.0% | 3.9% | 0.0% | 0.0% | NA | NA | NA |
Erythromycin | NA | NA | NA | NA | NA | 46.9 % | 65.2% | 50.0% |
Clindamycin | NA | NA | NA | NA | NA | 40.6% | NA | 62.5% |
Vancomycin | NA | NA | NA | NA | NA | 0.0% | 4.4% | 0.0% |